OSTERTAG ERIC (Chief Executive Officer) reported 1 transaction at POSEIDA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/3/2023ACC: 0001209191-23-006828
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2020
-11.78K
Net shares
Net seller
$82.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
11.78K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.78K
Price / share
$7.00
Trade value
$82.43K
% of position
1.4%
2/1/2023
839.10K→827.32K
Total
Net shares
−11.78K
Net value
-$82.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2023 | F · Tax Withholding | −11.78K | $7.00 | $82.43K | 1.4% | 839.10K | 827.32K |
| Total | −11.78K | -$82.43K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned3.66M
Common Stock
IndirectShares owned580.29K
Common Stock
IndirectShares owned961.45K
Total
5.20M indirect5.20M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.66M | Indirect |
| Common Stock | 580.29K | Indirect |
| Common Stock | 961.45K | Indirect |
| Total | 5.20M | 5.20M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported